ALEXANDRIA, Va., Feb. 17 -- United States Patent no. 12,551,490, issued on Feb. 17, was assigned to Sagimet Biosciences Inc. (San Mateo, Calif.).
"Heterocyclic modulators of lipid synthesis" was invented by Douglas I. Buckley (San Mateo, Calif.), Gregory Duke (San Mateo, Calif.), Allan S. Wagman (San Mateo, Calif.), Marc Evanchik (San Jose, Calif.) and Robert S. Mcdowell (San Francisco).
According to the abstract* released by the U.S. Patent & Trademark Office: "Compounds that are fatty acid synthesis modulators are provided. The compounds may be used to treat disorders characterized by disregulation of the fatty acid synthase function by modulating the function and/or the fatty acid synthase pathway. Methods are provided for treating suc...